Skip to content
Luke Rosen had hoped a new treatment would slow the progression of his daughter’s KIF1A Associated Neurological Disorder (KAND), but was amazed to see […]
PACE panel urges incentives for exciting new GTT drugs Read More »
Maintaining America’s biotechnology leadership requires Food and Drug Administration (FDA) modernization as well as Congressional action to reauthorize a program supporting rare disease research
BIO CEO John Crowley tells Senate how to support biotech Read More »
The FDA is hiring reviewers and finding ways to expedite drug approval, Dr. George Tidmarsh, Director of the Food and Drug Administration (FDA) Center
PACE: CDER director discusses faster approval, FDA morale with BIO CEO John F. Crowley Read More »
With Medicaid cuts expected, vaccine hesitancy getting politicized, and the continued challenge of Prescription Drug Affordability Boards (PDABs), state legislatures will drive many of
BIO PACE 2025: Patients need to ensure state policies enable access to medicine Read More »
Legislation establishing clear rules about the kinds of ideas that can be patented would support innovation in biotech and other fields by eliminating ambiguities
Senators seek patent clarity to support innovation Read More »
A concentration of scientific expertise, extensive manufacturing activity, and state support have helped make biotech one of the fastest-growing areas of employment in Illinois.
BIO on the American Road: Biotech innovation and job growth in Illinois Read More »
Already providing employment for 129,245 people and $95 billion in annual economic output, Texas’s biotech sector is growing rapidly. That sector will be highlighted
BIO’s Texas visit will highlight a growing biotech ecosystem Read More »
The federal government’s program that provides seed funding to support research by biotech startups provides much more than money, said program officials and small
BIO 2025: Federal seed funding also comes with valuable advice Read More »
Litigation opposing drug price controls in the Inflation Reduction Act (IRA) has yet to have a major impact, but the cases are still ongoing
BIO 2025: Legal experts break down cases against IRA price controls Read More »
With more than $1 billion in R&D expenditures in 2022 and 415 new patents in 2023, the bioscience sector in Virginia is making an
BIO visit shines a spotlight on Virginia’s biotech ecosystem Read More »
